Key Details
Price
$389.00Last Dividend
$0.80PE Ratio
41.69Annual ROE
17.98%Beta
-Events Calendar
Next earnings date:
Jan 30, 2025Recent quarterly earnings:
Oct 29, 2024Recent annual earnings:
Jan 30, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Sept 30, 2024Next split:
N/ARecent split:
May 17, 2004Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
SYK has introduced the Oculan Lighting Platform to enhance lighting in operating rooms, helping surgeons work with greater precision. This new system aims to improve visibility during procedures.
Investors are paying close attention to Stryker Corporation (SYK) due to its impressive financial results.
On November 19, 2024, in Flower Mound, Texas, Stryker, a leading company in medical technology, introduced the Oculan Lighting Platform. This new lighting system aims to offer reliable and high-quality light, helping surgeons maintain their focus on providing excellent care. In modern operating rooms, where precision is vital, even minor issues can affect surgical results, making clear visibility essential for surgeons.
Stryker has introduced the latest version of SurgiCount+ to improve the management of sponges and the evaluation of blood loss in hospitals.
SYK's results for the third quarter show good performance in different areas and an increase in operating margin.
Stryker Corporation (NYSE:SYK) will hold its Q3 2024 Earnings Conference Call on October 29, 2024, at 4:30 PM ET. The call will feature company leaders, including Kevin Lobo, the Chair and CEO, and Jason Beach, the Vice President of Finance and Investor Relations. Various analysts from major financial institutions will also participate in the call.
Stryker (SYK) reported quarterly earnings of $2.87 per share, which is higher than the Zacks Consensus Estimate of $2.78 per share. This is an increase compared to earnings of $2.46 per share from the same period last year.
SYK's results for the third quarter of 2024 are anticipated to show good performance in different areas. Nevertheless, increasing costs are probably still affecting profit margins.
Assess the anticipated performance of Stryker (SYK) for the quarter that ended in September 2024. Instead of just focusing on the usual Wall Street revenue and profit predictions, let's take a closer look at some important metrics for a deeper understanding.
Stryker Corporation's stock is advised as a Buy because of its consistent earnings growth, better profit margins, and smart acquisitions, with a one-year price target that is 12.66% higher. Recent financial results indicate strong performance, with net sales increasing by 8.5% and adjusted EPS rising by 10.6%, along with a solid balance sheet and lower long-term debt. The company's growth potential is backed by organic growth, acquisitions, and improving margins, along with a small but increasing dividend, making it appealing for growth investors.
FAQ
- What is the primary business of Stryker?
- What is the ticker symbol for Stryker?
- Does Stryker pay dividends?
- What sector is Stryker in?
- What industry is Stryker in?
- What country is Stryker based in?
- When did Stryker go public?
- Is Stryker in the S&P 500?
- Is Stryker in the NASDAQ 100?
- Is Stryker in the Dow Jones?
- When was Stryker's last earnings report?
- When does Stryker report earnings?
- Should I buy Stryker stock now?